2026 Could Mark Biotech Innovation Turning Point

2026 promises a breakthrough year for American biotech innovation, with FDA's push to ditch outdated animal testing for human-relevant models like organ-on-a-chip boosting drug success rates and slashing failures from flawed trials. AI integrates into regulated drug development, speeding trials, patient matching, and endpoints while proving real efficiency gains. Read more about this...